TCMD
NEUTRALAt a glance
Key valuation, profitability, growth, and risk metrics.
AI Analysis
AI-powered fundamental assessment
Key Strengths
Key Risks
Performance Snowflake
Multi-dimensional analysis across 5 key categories
Ref P/E 31.12, PEG 17.79, Graham $13.42
- Forward P/E (17.30) is significantly lower than current P/E
- Price ($25.52) exceeds Intrinsic Value ($24.19)
- Extreme PEG ratio (17.79)
- Price is nearly double the Graham Number ($13.42)
Ref Growth rates vs SEC Risk Factors
- Strong 21% YoY revenue growth
- Scalable home-care delivery model
- CMS PAR requirements may increase claim denials and delays
- Potential for unfavorable NCD/LCD interpretations
Ref Historical price and earnings trends
- Strong 1Y price performance (+89.7%)
- Frequent earnings beats
- Poor 5Y long-term performance (-55.1%)
Ref Piotroski 4/9, Debt/Equity 0.07
- Extremely low Debt/Equity (0.07)
- High Current Ratio (4.03) and Quick Ratio (3.49)
- Piotroski F-Score is only 'Stable' (4/9)
Ref Yield N/A
- No dividend history or current yield
Stock Price & Analyst Targets
Real-time price movements and analyst price targets
Multi-Horizon Performance vs Peers
Price momentum across 5Y → 1W horizons for TCMD and closest competitors.
| Company | 5Y | 3Y | 1Y | 6M | 1M | 1W |
|---|---|---|---|---|---|---|
|
TCMD
Tactile Systems Technology, Inc.
Primary
|
-55.1% | +37.4% | +89.7% | +74.7% | -2.2% | +5.3% |
|
MDXG
MiMedx Group, Inc.
Peer
|
-67.5% | +18.4% | -42.1% | -39.8% | -10.5% | +1.0% |
|
LYEL
Lyell Immunopharma, Inc.
Peer
|
-92.7% | -47.5% | +178.7% | +47.4% | +16.7% | +14.3% |
|
PRTA
Prothena Corporation plc
Peer
|
-54.1% | -79.5% | +18.5% | +9.9% | +26.9% | +3.8% |
|
HSTM
HealthStream, Inc.
Peer
|
-8.4% | -25.8% | -36.2% | -22.1% | -3.1% | -2.8% |
Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.
Historical Performance Trends
Long-term financial metrics and growth patterns
Revenue & Net Income
Profit & Operating Margins
Return on Equity (ROE)
Quarterly Revenue Growth
Valuation Metrics
Key valuation ratios and pricing indicators
Profitability
Profit margins and return metrics
Growth
Revenue and earnings growth rates
Financial Health
Balance sheet strength and liquidity metrics
Financial Statement Flow
Interactive flow visualization showing how money moves through the company Q4 2025
Quarterly Earnings History
EPS performance vs analyst estimates
Healthcare Sector Comparison
Similar Companies
Peer comparison within the same industry
| Company | AI Rating | Market Cap | P/E | ROE | Profit Margin | Price | |
|---|---|---|---|---|---|---|---|
|
TCMD
Tactile Systems Technology, Inc.
|
NEUTRAL | $580.59M | 31.12 | 8.8% | 5.8% | $25.52 | |
|
MDXG
MiMedx Group, Inc.
|
NEUTRAL | $582.38M | 12.25 | 21.6% | 11.6% | $3.92 | Compare |
|
LYEL
Lyell Immunopharma, Inc.
|
BEARISH | $578.54M | - | -87.0% | -% | $24.8 | Compare |
|
PRTA
Prothena Corporation plc
|
BEARISH | $586.78M | - | -63.6% | -% | $10.9 | Compare |
|
HSTM
HealthStream, Inc.
|
BEARISH | $589.8M | 32.59 | 5.1% | 6.0% | $19.88 | Compare |
Recent Insider Trading
Insider buy and sell transactions from the last 6 months
| Date | Insider | Position | Transaction | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-09 | PEARSON ANDREA | Director | Stock Award | 852 | - |
| 2026-02-24 | DODD SHERI LOUISE | Chief Executive Officer | Sale | 10,993 | $318,144 |
| 2026-02-24 | BURNS KRISTIE | Officer | Sale | 6,246 | $180,764 |
| 2026-02-24 | BIRKEMEYER ELAINE M | Chief Financial Officer | Sale | 7,701 | $222,880 |
| 2026-02-23 | DODD SHERI LOUISE | Chief Executive Officer | Sale | 15,240 | $431,245 |
| 2026-02-23 | BURNS KRISTIE | Officer | Sale | 4,439 | $125,612 |
| 2026-02-23 | BIRKEMEYER ELAINE M | Chief Financial Officer | Sale | 5,518 | $156,144 |
| 2026-02-20 | DODD SHERI LOUISE | Chief Executive Officer | Stock Award | 47,967 | - |
| 2026-02-20 | BURNS KRISTIE | Officer | Stock Award | 14,671 | - |
| 2026-02-20 | BIRKEMEYER ELAINE M | Chief Financial Officer | Stock Award | 25,919 | - |
| 2026-02-19 | DODD SHERI LOUISE | Chief Executive Officer | Stock Award | 48,672 | - |
| 2026-02-19 | BURNS KRISTIE | Officer | Stock Award | 6,194 | - |
| 2026-02-19 | BIRKEMEYER ELAINE M | Chief Financial Officer | Stock Award | 23,008 | - |
| 2026-01-02 | BURNS KRISTIE | Officer | Sale | 5,139 | $148,260 |
SEC Filings
Recent regulatory filings from the SEC EDGAR database
Tactile Systems Technology, Inc. (TCMD) provides medical devices for the at-home treatment of chronic vascular, oncology, and respiratory conditions. While specific financial metrics were not provided in the excerpts, the company focuses on a scalable home care delivery model designed to reduce healthcare expenditures. A primary risk to the business is the potential for changes to Medicare coverage or reimbursement criteria, which could adversely affect financial results.
Wall Street Analysts
Professional analyst ratings and price targets
Past News Coverage
Recent headlines mentioning TCMD from our newsroom.